30% supramolecular salicylic acid combined with supramolecular active zinc
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 30% supramolecular salicylic acid combined with supramolecular active zinc, covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of 30% Supramolecular Salicylic Acid Combined With Supramolecular Active Zinc in the Treatment of Malassezia Folliculitis [Phase 4]